Will be held at the Dimiccoli hospital in Barlettaat the University Centre of the ASL Bt, Friday 5th and Saturday 6th July, the scientific congress entitled “Prostate cancer: current situation and perspectives”, by the Prof. Giuseppe GuglielmiFull Professor of Radiology at the University of Foggia and Head of the UOSVD Radiology at the Dimiccoli hospital in Barletta and of the Prof. Luigi CormioProfessor of Urology at the University of Foggia and Director of the Urology and Andrology Unit at the Bonomo Hospital in Andria.
The congress, sponsored by the ASL Bt, includes five working sessions and will open on Friday 5 July at 8.30 am with institutional greetings from the General Director of Asl Bt Tiziana Dimatteo and the Rector of the University of Foggia Lorenzo Lo Muzio.
Prostate cancer affects middle-aged men between the ages of 45 and 60 and is a leading cause of death in men globally, after lung disease.
There is no single specific test for prostate cancer, however, diagnosis is conventionally made by digital rectal examination (DRE). The prostate-specific antigen (PSA) test, however, remains the cornerstone of prostate cancer screening.
To confirm the presence of cancer, a biopsy of prostate tissue is usually performed. During the biopsy, the prostate gland is usually located with devices such as magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS).
The available treatment options for prostate cancer are active surveillance, chemotherapy, radiation therapy, hormone therapy, surgery, and cryotherapy. The treatment options provided to the patient depend on the nature of the tumor, the PSA level, the grade and stage, and the possibility of recurrence.
